Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant 2018-06-11 20:00
The 4th annual China-US Innovation Competition hosted by the Entrepreneur Foundation 2018-06-06 14:53
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership 2018-05-30 08:34
WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore 2018-05-22 18:34
WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis' Lead Investigational Candidate to Treat Brain Cancer 2018-05-21 20:30
WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang 2018-05-16 18:09
Sinovac Files 2017 Annual Report on Form 20-F and Reports Unaudited Second Half, Audited Full Year 2017 Financial Results 2018-05-11 21:10
Sinovac Forced to Temporarily Suspend Hepatitis A Vaccine Production Line Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing 2018-05-08 21:29
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange 2018-05-08 11:44
WuXi STA Changzhou Site Passes First U.S. FDA Inspection 2018-05-07 08:00
China Biologic Reports Financial Results for the First Quarter of 2018 2018-05-05 04:30
Sinovac Forced to Temporarily Suspend Flu Vaccine Production Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing 2018-05-01 19:00
Sinovac Forced to Plan to Destroy Bacterial Seeds intended for Pneumo Vaccine Production and Postpone Site Inspection 2018-04-30 21:25
Sinovac Temporarily Blocks Access to Its Websites 2018-04-30 21:00
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland 2018-04-30 20:41
Sinovac to Delay Filing of 2017 Annual Report on Form 20-F Following Actions Taken by the Minority Shareholder of Sinovac Beijing 2018-04-27 20:30
Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction 2018-04-27 19:31
WuXi STA Announces to Build a New R&D Center in Shanghai 2018-04-27 08:00
Innovent Biologics completed US$150 million Series E round financing 2018-04-26 20:47
Samsung BioLogics becomes the first in the South Korean pharma industry to achieve ISO 22301 Certificate 2018-04-25 16:09
1 136 137 138 139 140 220